FDA Urges 2,200 Sponsors to Publicly Disclose Trial Results

TL;DR Summary
The FDA reminded more than 2,200 sponsors and researchers to submit mandatory clinical trial results to ClinicalTrials.gov, flagging risks from publication bias and incomplete public records. An internal review found about 29.6% of studies likely required to report have no results, and the agency issued voluntary compliance messages on March 30, 2026, with potential for noncompliance notices to ensure results are released for patient safety and informed clinical decisions.
- FDA Reminds More Than 2,200 Sponsors and Researchers to Disclose Trial Results fda.gov
- F.D.A. Calls on Drug Developers to Publish Missing Data from Thousands of Trials The New York Times
- FDA urges clinical trial sponsors to report the results of their studies Fierce Biotech
- FDA Urges Pharma to Publish Trial Data, Warns of 'Distorted' Evidence Base MedPage Today
- FDA reminds sponsors, researchers to disclose clinical trial results AuntMinnie
Reading Insights
Total Reads
0
Unique Readers
25
Time Saved
3 min
vs 3 min read
Condensed
88%
582 → 69 words
Want the full story? Read the original article
Read on fda.gov